The first stop for professional medicines advice

Administering

54 results

Applied filters

Choosing between oral vancomycin options

18 May 2021Local decision makers should choose between the options for giving vancomycin orally. Licensing status and other factors affect decision making.

Making best use of restricted aseptic compounding capacity

18 September 2018The NHS is experiencing considerable challenges regarding the supply of aseptically prepared injectable medicines. This communication from NPSG advises all NHS customers of commercial aseptic…

Guidance on the Pharmaceutical Issues concerning Outpatient Parenteral Antibiotic Therapy (OPAT) and other Outpatient IV Therapy Services 1st Edition January 2018

30 July 2018The development of OPAT (Outpatient Parenteral Antibiotic Therapy) services and other outpatient intravenous therapies has been rapid over recent years and there are many models…

About SPS Cytotoxic Drug and Biopharmaceutical Stability monographs and advice

24 August 2020Validated stability data ensures products compounded by cytotoxic reconstitution processes within aseptic units are safe for patients

Choosing between oral fidaxomicin options

20 October 2021Local decision makers should choose between the options for giving fidaxomicin orally. Licensing status and other factors affect decision making.

Preventing parenteral nutrition rapid over-infusion in babies

28 October 2022There is a risk of severe harm or death if PN is unintentionally infused too rapidly in babies. Healthcare professionals need to ensure safe practice.

Including medicines with Risk Minimisation Measures (RMM) in PGDs

16 March 2021Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.

Using a Patient Group Direction to adjust doses of medicines

16 November 2021This article outlines why PGDs cannot be used to adjust the dosage of a medicine already in an individual's possession.

Off label medicine use under a Patient Group Direction

10 June 2021This article explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label').

Unlicensed medicines and use of PGDs

16 November 2021This page explains why PGDs are not a legal mechanism for the administration or supply of unlicensed medicines.
admin